Table 3.
Characteristics of the study participants
| Total | ||
|---|---|---|
| n = 18 | % | |
| Age (years) | ||
| Mean [SD] | 58.11 [11.35] | |
| Gender | ||
| Male | 7 | 38.89 |
| Female | 11 | 61.11 |
| Different cancer types | ||
| Bile duct | 2 | 11.11 |
| Breast | 2 | 11.11 |
| Colon | 5 | 27.78 |
| Hodgkin’s lymphoma | 2 | 11.11 |
| Lung | 2 | 11.11 |
| Ovary | 1 | 5.56 |
| Pancreas | 1 | 5.56 |
| Rectal | 2 | 11.11 |
| Sigma | 1 | 5.56 |
| Time (days with catheter) | ||
| Mean [SD] | 155.61 [128.00] | |
| Cause catheter placement | ||
| Chemotherapy in continuous perfusion 24 h | 5 | 27.78 |
| Limited peripheral venous access | 12 | 66.67 |
| Vesicant chemotherapy | 1 | 5.56 |
| Dominant arm | ||
| No | 12 | 66.67 |
| Yes | 6 | 33.33 |
| Previous PICC | ||
| No | 14 | 77.78 |
| Yes | 4 | 22.22 |